Source: Pharmacy Times articles
Amplification of chromosome 1q is associated with poorer treatment outcomes for patients with relapsed/refractory and newly diagnosed multiple myeloma.
Read More
by | Jun 13, 2024 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Amplification of chromosome 1q is associated with poorer treatment outcomes for patients with relapsed/refractory and newly diagnosed multiple myeloma.
Read More